Opioid maker Purdue submits US$10 billion Chapter 11 plan
A year and a half since it entered bankruptcy, Purdue Pharma has submitted a U$10 billion Chapter 11 plan before a New York court that it says will shift it from opioid drug marketer to a company owned by a public trust dedicated to addressing addiction.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10